Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung.

Market Analysis and Insights: Global BRAHMS Procalcitonin (PCT) Market
In 2020, the global BRAHMS Procalcitonin (PCT) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global BRAHMS Procalcitonin (PCT) Scope and Market Size
The global BRAHMS Procalcitonin (PCT) market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global BRAHMS Procalcitonin (PCT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Procalcitonin Antigen
Procalcitonin Antibody

Segment by Application
Medical Industry
Veterinarian
Scientific Research

By Company
Thermo Fisher
Roche Diagnostics
bioMerieux
Siemens
Samsung
Abbott
Fujirebio

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE